Ribavirin Impairs Salivary Gland Function in Hepatitis C Patients During Combination Treatment With Pegylated Interferon Alfa-2a
Alessio Aghemo, Massimo Colombo(University of Milan), Antonio Russo(Health Protection Agency), Matteo Banderali(University of Milan), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), F Ottaviani(University of Milan), Sara Monico(University of Milan), Maria Grazia Rumi(University of Milan), Mauro Viganò(Ospedale San Giuseppe)
Cited by 11
Related Papers
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539